Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03263650
Title Randomized Phase II Study of Olaparib Maintenance Following Cabazitaxel-Carbo in Men With AVPC
Recruitment Active, not recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

prostate carcinoma

Therapies

Cabazitaxel + Carboplatin

Olaparib

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.